DrugPredict Wins $2.8M NIH Grant to Repurpose Approved Therapies to Treat Alzheimer’s

DrugPredict Wins $2.8M NIH Grant to Repurpose Approved Therapies to Treat Alzheimer’s
A group of U.S. researchers hoping to identify already approved medications to repurpose as Alzheimer’s disease treatments has won a $2.8 million, five-year grant from the National Institute on Aging, a division of the National Institutes of Health (NIH). The study will be led by scientists at Ohio’s Case Western Reserve University School of Medicine. The group recently

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *